The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic polymorphisms and sunitinib outcome in metastatic renal-cell carcinoma: A prospective observational study and validation.
Carlos A. Farfán
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose
Cristina Rodriguez-Antona
No relevant relationships to disclose
Julio Benitez
No relevant relationships to disclose
Guillermo De Velasco
No relevant relationships to disclose
Felipe Villacampa
No relevant relationships to disclose
Federico de la Rosa
No relevant relationships to disclose
Eva Andres
No relevant relationships to disclose
Juan Manuel Sepúlveda
No relevant relationships to disclose